Guanfacine Tablet, Extended Release
Product Images NDC 72162-1798

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Guanfacine (NDC 72162-1798). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721621798)

Each extended-release tablet contains 1 mg of Guanfacine, as Guanfacine Hydrochloride, USP. Guanfacine Extended-Release Tablets should be kept out of the reach of children and stored at 20° to 25°C (68° to 77°F). These tablets should not be crushed, chewed, or broken before swallowing. For more information, refer to the provided link.*

FDA Label Image

Spl-fig-1 (Spl Fig 1)

FDA Label Image

Spl-fig-2 (Spl Fig 2)

This text provides information about the change due to PK fold change and 90% CI for CYP3A4 inhibitors (Ketoconazole) and inducers (Rifampin), as well as the concentration levels for oral Methylphenidate and Lisdexamfetamine Dimesylate. It also mentions the change relative to the reference in the chart provided.*

FDA Label Image

Spl-fig-3 (Spl Fig 3)

This text contains information about the fold change in pharmacokinetics (PK) of interacting drugs, specifically oral Methylphenidate and Lisdexamfetamine Dimesylate. It includes parameters such as Cmax and AUC, with data presented in the form of relative changes compared to a reference.*

FDA Label Image

Spl-fig-4 (Spl Fig 4)

FDA Label Image

Spl-structure (Spl Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.